GlassScriptPhysician profile
Anushka Magal
NPI 1003346248
$1,682.85
in general payments reported to CMS, 2019-2025
25 companies · $442 in 2025
The $442 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.33 · 2020: $24.87 · 2021: $364 · 2022: $439 · 2023: $199 · 2024: $180 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.67 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $283.57 | 2022-2025 | |
| Myovant Sciences INC. | $147.08 | 2021 | |
| Baxter Healthcare | $123.50 | 2019-2025 | Tisseel, Floseal |
| Aspira Women'S Health INC | $110.87 | 2022-2024 | Ova1 |
| Agile Therapeutics, INC. | $101.78 | 2021 | |
| Exeltis, USA INC. | $71.36 | 2023-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $71.13 | 2021-2024 | |
| Astellas Pharma US INC | $60.85 | 2023-2024 | Veozah |
| Biogen, INC. | $55.22 | 2025 | Zurzuvae |
| Organon LLC | $48.17 | 2022-2024 | |
| Optumhealth Care Solutions, LLC | $47.74 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coloplast Corp | $37.96 | 2022 | |
| Scynexis, INC. | $36.80 | 2022 | |
| Merck Sharp & Dohme LLC | $29.96 | 2022-2024 | Gardasil 9, Gardasil |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $22.69 | 2025 | Intrarosa |
| Hydrofera LLC | $19.15 | 2025 | Hydrofera Blue |
| Intuitive Surgical, INC. | $18.34 | 2021 | |
| Smith+Nephew, INC. | $18.33 | 2023 | Pico 7, Pico 14, Renasys Go V2 Home |
| Hologic Sales and Service, LLC | $17.76 | 2023 | Aptima |
| Currax Pharmaceuticals LLC | $17.06 | 2022 | |
| Lilly USA, LLC | $16.48 | 2025 | Zepbound, Mounjaro |
| Pfizer INC. | $13.25 | 2024 | |
| Therapeuticsmd, INC. | $11.82 | 2021 | |
| Evofem Biosciences, INC. | $6.31 | 2025 | Solosec, Phexx, Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anushka Magal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.